Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 42
- Registration Number
- NCT00000733
- Locations
- 🇺🇸
Charity Hosp / Tulane Univ Med School, New Orleans, Louisiana, United States
🇺🇸Tulane Univ School of Medicine, New Orleans, Louisiana, United States
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 3200
- Registration Number
- NCT00000736
- Locations
- 🇺🇸
Montefiore Med Ctr / Bronx Municipal Hosp, Bronx, New York, United States
🇺🇸Bronx Municipal Hosp Ctr/Jacobi Med Ctr, Bronx, New York, United States
🇺🇸SUNY / Erie County Med Ctr at Buffalo, Buffalo, New York, United States
Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 20
- Registration Number
- NCT00000761
- Locations
- 🇺🇸
The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia, Pennsylvania, United States
🇺🇸Texas Children's Hosp. CRS, Houston, Texas, United States
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
- Conditions
- Cytomegalovirus InfectionsHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 32
- Registration Number
- NCT00000805
- Locations
- 🇺🇸
Columbia IMPAACT CRS, New York, New York, United States
🇺🇸Tulane/LSU Maternal/Child CRS, New Orleans, Louisiana, United States
🇺🇸Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab., Oakland, California, United States
A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 30
- Registration Number
- NCT00001006
- Locations
- 🇺🇸
Mount Sinai Med Ctr, New York, New York, United States
A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine
- Conditions
- HIV SeronegativityHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 60
- Registration Number
- NCT00001136
- Locations
- 🇺🇸
JHU AVEG, Baltimore, Maryland, United States
🇺🇸UAB AVEG, Birmingham, Alabama, United States
🇺🇸Univ. of Rochester AVEG, Rochester, New York, United States
Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 80
- Registration Number
- NCT00006495
- Locations
- 🇺🇸
Univ. of Texas Medical Branch, ACTU, Galveston, Texas, United States
🇺🇸Univ. of Miami AIDS CRS, Miami, Florida, United States
🇺🇸UCLA CARE Center CRS, Los Angeles, California, United States
Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 94
- Registration Number
- NCT00011011
- Locations
- 🇺🇸
Univ. of Pennsylvania Health System, Presbyterian Med. Ctr., Philadelphia, Pennsylvania, United States
🇺🇸The Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸Alabama Therapeutics CRS, Birmingham, Alabama, United States
Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
- Conditions
- PregnancyHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 24
- Registration Number
- NCT00000920
- Locations
- 🇺🇸
Columbia Presbyterian Med Ctr, New York, New York, United States
🇺🇸Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
🇺🇸Children's Hosp of Michigan, Detroit, Michigan, United States
A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)
- Conditions
- HIV InfectionsAIDS-Associated Nephropathy
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 54
- Registration Number
- NCT00000819
- Locations
- 🇺🇸
Beth Israel Med. Ctr. (Mt. Sinai), New York, New York, United States
🇺🇸Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States
🇺🇸Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States